Publications by authors named "Maria C Chillon"

Claim this Profile
I
Interlaboratory cross validation of acute myeloid leukemia fusion genes and mutational targets detected by PCR: Performance of PETHEMA central laboratories.
Margarida Coucelo, Claudia Sargas, Rosa Ayala, María J Larráyoz, María Carmen Chillón

Leuk Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic relevance of variant allele frequency for treatment outcomes in patients with acute myeloid leukemia: a study by the Spanish PETHEMA registry.
Rafael Colmenares, Noemi Alvarez, Eva Barragan, Blanca Boluda, Maria J Larrayoz, Maria Carmen Chillon

Haematologica· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conventional PCR Versus Next Generation Sequencing for Diagnosis of FLT3, IDH and NPM1 Mutations in Acute Myeloid Leukemia: Results of the PETHEMA PCR-LMA Study.
Blanca Boluda, Rebeca Rodriguez-Veiga, Claudia Sargas, Rosa Ayala, María J Larráyoz

Cancers (Basel)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolving patterns and clinical outcome of genetic studies performed at diagnosis in acute myeloid leukemia patients: Real life data from the PETHEMA Registry.
Jorge Labrador, David Martínez-Cuadrón, Blanca Boluda, Josefina Serrano, Cristina Gil

Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of mutated bZIP as a distinct prognosis entity in acute myeloid leukemia: a study by the Spanish PETHEMA registry.
Esther Prados De la Torre, Josefina Serrano, David Martínez-Cuadrón, Laura Torres, Claudia Sargas

Haematologica· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-Cell DNA Sequencing and Immunophenotypic Profiling to Track Clonal Evolution in an Acute Myeloid Leukemia Patient.
María García-Álvarez, Ana Yeguas, Cristina Jiménez, Alejandro Medina-Herrera, Verónica González-Calle

Biomedicines· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline immunophenotypic profile of bone marrow leukemia cells in acute myeloid leukemia with nucleophosmin-1 gene mutation: a EuroFlow study.
Sergio Matarraz, Pilar Leoz, Ana Yeguas-Bermejo, Vincent van der Velden, Anne E Bras

Blood Cancer J· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal architecture and evolutionary history of Waldenström's macroglobulinemia at the single-cell level.
Ramón García-Sanz, María García-Álvarez, Alejandro Medina, Elham Askari, Verónica González-Calle

Dis Model Mech· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Intracellular Drug Disposition in the Response of Acute Myeloid Leukemia to Cytarabine and Idarubicin Induction Chemotherapy.
Gabriela Rodríguez-Macías, Oscar Briz, Candela Cives-Losada, María C Chillón, Carolina Martínez-Laperche

Cancers (Basel)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group.
Claudia Sargas, Rosa Ayala, María J Larráyoz, María C Chillón, Eduardo Rodriguez-Arboli

Blood Cancer J· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry.
Claudia Sargas, Rosa Ayala, María José Larráyoz, María Carmen Chillón, Estrella Carrillo-Cruz

Cancers (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of FLT3-ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study.
Rosa Ayala, Gonzalo Carreño-Tarragona, Eva Barragán, Blanca Boluda, María J Larráyoz

Cancers (Basel)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of the novel HLA-A*23:01:01:27 allele in an acute myeloid patient and related donor.
Miguel Bastos, Miguel Alcoceba, María Carmen Chillón, Ramón García-Sanz, Francisco Boix

HLA· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and Outcomes of Adult Patients in the PETHEMA Registry with Relapsed or Refractory -ITD Mutation-Positive Acute Myeloid Leukemia.
David Martínez-Cuadrón, Josefina Serrano, José Mariz, Cristina Gil, Mar Tormo

Cancers (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Mutations: Transforming the Landscape of IgM Monoclonal Gammopathies.
Miguel Alcoceba, María García-Álvarez, Alejandro Medina, Rebeca Maldonado, Verónica González-Calle

Int J Mol Sci· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML project.
Claudia Sargas, Rosa Ayala, María Carmen Chillón, María J Larráyoz, Estrella Carrillo-Cruz

Haematologica· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The novel HLA-DQB1*06:03:27 allele characterised by sequence-based typing in a European bone marrow donor.
Francisco Boix, María Carmen Chillón, Sergio García-Sánchez, Miguel Alcoceba, Luis Alberto Marín-Rubio

HLA· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allele and haplotype frequencies of HLA-A, -B, -C, -DRB1, -DQB1 and -DQA1 in Castile and Leon region from North West of Spain.
Francisco Boix, Luis Alberto Marín-Rubio, Miguel Alcoceba, María García-Álvarez, María Carmen Chillón

Hum Immunol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of relapse-associated gene mutations by next-generation sequencing in low-risk acute myeloid leukaemia patients.
María Isabel Prieto-Conde, Cristina Jiménez, María García-Álvarez, Fernando Ramos, Alejandro Medina

Br J Haematol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical significance of complex karyotype at diagnosis in pediatric and adult patients with de novo acute promyelocytic leukemia treated with ATRA and chemotherapy.
Jorge Labrador, Elisa Luño, Edo Vellenga, Salut Brunet, José González-Campos

Leuk Lymphoma· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exportin-1 E571K mutation is a common finding in patients with classical Hodgkin lymphoma.
Almudena Navarro-Bailón, Cristina Jiménez, Sara Alonso-Álvarez, Miguel Alcoceba, Verónica González-Calle

Hematol Oncol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Basophil-lineage commitment in acute promyelocytic leukemia predicts for severe bleeding after starting therapy.
Sergio Matarraz, Pilar Leoz, Carlos Fernández, Enrique Colado, María Carmen Chillón

Mod Pathol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of peripheral neuropathy in multiple myeloma patients receiving bortezomib and thalidomide: a genetic study based on a single nucleotide polymorphism array.
Ramón García-Sanz, Luis Antonio Corchete, Miguel Alcoceba, María Carmen Chillon, Cristina Jiménez

Hematol Oncol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Next-Generation Sequencing Strategy for Evaluating the Most Common Genetic Abnormalities in Multiple Myeloma.
Cristina Jiménez, María Jara-Acevedo, Luis A Corchete, David Castillo, Gonzalo R Ordóñez

J Mol Diagn· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CIP2A high expression is a poor prognostic factor in normal karyotype acute myeloid leukemia.
Eva Barragán, María Carmen Chillón, Remedios Castelló-Cros, Nerea Marcotegui, María Isabel Prieto

Haematologica· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis